Back to Journals Drug Design, Development and Therapy Volume 16 The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases Authors Cheng D, Yang S, Zhao X, Wang G Received 5 November 2021 Accepted for publication 18 February 2022 Published 14 March 2022 Volume 2022:16 Pages 665684 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Tuo Deng Dihe Cheng, Shuo Yang, Xue Zhao, Guixia Wang Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021, Peoples Republic of China Correspondence: Guixia Wang
Tips for Reducing Injection-Related Bruising Download our GLP-1 app to Turn Your Weight Loss Journey into Your Favorite Game Does Semaglutide Cause Bruising
Beckys Holiday Gift Guide Elevate Your Holidays With Dr
These investigations provide insight into how peptides can influence complex vascular and regenerative systems at a molecular level
Because the half-life is 20-30 hours, one injection per day produces relatively stable receptor coverage
Beyotime) were used for detection, followed by hematoxylin counterstaining